Black Diamond Therapeutics Inc (BDTX)
Fair Value2.7% Upside
Fair
Analyst450.7% Upside
Market Cap102 M
P/E-2.4x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Bolt Biotherapeutics (BOLT)
Fair Value41.1% Upside
Undervalued
Analyst938.0% Upside
Market Cap7.59 M
P/E-0.3x
Yield0.0%
HealthFair
NASDAQ
Briacell Therapeutics Corp (BCTX)
Fair Value27.7% Upside
Undervalued
Market Cap29.244 M
P/E-1.0x
Yield0.0%
HealthWeak
NASDAQ
BridgeBio Pharma Inc (BBIO)
Fair Value-3.6% Downside
Fair
Analyst29.5% Upside
Market Cap16.044 B
P/E-22.2x
Yield0.0%
HealthGood
NASDAQ
Burning Rock Biotech Ltd (BNR)
Fair Value45.6% Upside
Undervalued
Market Cap94.601 M
P/E-10.7x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
C4 Therapeutics Inc (CCCC)
Fair Value5.3% Upside
Fair
Analyst268.3% Upside
Market Cap399.1 M
P/E-3.9x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Cabaletta Bio Inc (CABA)
Fair Value-1.5% Downside
Fair
Analyst393.5% Upside
Market Cap451.7 M
P/E-2.5x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Candel Therapeutics Inc (CADL)
Fair Value-32.4% Downside
Overvalued
Analyst96.0% Upside
Market Cap770.1 M
P/E-14.1x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Momentum Stocks
Small-Cap Stocks
Caribou Biosciences Inc (CRBU)
Fair Value27.9% Upside
Undervalued
Analyst645.3% Upside
Market Cap155.7 M
P/E-1.2x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Celularity Inc (CELU)
Fair Value22.5% Upside
Undervalued
Market Cap20.361 M
P/E-0.2x
Yield0.0%
HealthFair
NASDAQ
Century Therapeutics Inc (IPSC)
Fair Value0.2% Upside
Fair
Analyst141.7% Upside
Market Cap362.5 M
P/E-3.3x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Chemomab Therapeutics Ltd DRC (CMMB)
Fair Value-7.9% Downside
Fair
Analyst185.7% Upside
Market Cap12.097 M
P/E-1.7x
Yield0.0%
HealthFair
NASDAQ
Cibus Inc (CBUS)
Fair Value-6.8% Downside
Fair
Analyst659.9% Upside
Market Cap146.6 M
P/E-1.5x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Clene Inc. (CLNN)
Fair Value-4.7% Downside
Fair
Analyst498.5% Upside
Market Cap67.469 M
P/E-2.1x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
Climb Bio Inc (CLYM)
Fair Value-6.8% Downside
Fair
Analyst68.4% Upside
Market Cap719.2 M
P/E-13.5x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Compass Pathways Plc (CMPS)
Fair Value-23.0% Downside
Overvalued
Analyst74.9% Upside
Market Cap1.592 B
P/E-8.3x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Connect Biopharma Holdings Ltd (CNTB)
Fair Value-27.7% Downside
Overvalued
Analyst226.8% Upside
Market Cap130.3 M
P/E-2.1x
Yield0.0%
HealthWeak
NASDAQ
Featured in
Overvalued Stocks
Cullinan Oncology LLC (CGEM)
Fair Value-17.7% Downside
Fair
Analyst79.5% Upside
Market Cap1.079 B
P/E-4.9x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
Small-Cap Stocks
Cyclerion Therapeutics Inc (CYCN)
Fair Value1.4% Upside
Fair
Analyst125.4% Upside
Market Cap14.887 M
P/E-2.9x
Yield0.0%
HealthFair
NASDAQ
Damora Therapeutics Inc (DMRA)
Fair Value-39.8% Downside
Overvalued
Analyst44.9% Upside
Market Cap1.848 B
P/E-8.1x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
Technical Strength Leaders
Small-Cap Stocks
Dermata Therapeutics Inc (DRMA)
Fair Value32.4% Upside
Undervalued
Analyst241.9% Upside
Market Cap4.424 M
P/E-0.7x
Yield0.0%
HealthWeak
NASDAQ
Design Therapeutics Inc (DSGN)
Fair Value-31.9% Downside
Overvalued
Analyst54.8% Upside
Market Cap826.1 M
P/E-12.0x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
Small-Cap Stocks
DiaMedica Therapeutics Inc (DMAC)
Fair Value-16.4% Downside
Fair
Analyst132.6% Upside
Market Cap352.4 M
P/E-10.2x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Dianthus Therapeutics Inc (DNTH)
Fair Value-27.2% Downside
Overvalued
Analyst14.3% Upside
Market Cap6.035 B
P/E-35.4x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
Disc Medicine Inc (IRON)
Fair Value-8.3% Downside
Fair
Analyst28.0% Upside
Market Cap2.987 B
P/E-12.3x
Yield0.0%
HealthFair
NASDAQ
Dogwood Therapeutics Inc (DWTX)
Fair Value4.3% Upside
Fair
Analyst665.0% Upside
Market Cap60.197 M
P/E-2.2x
Yield0.0%
HealthFair
NASDAQ
Dyne Therapeutics Inc (DYN)
Fair Value-17.0% Downside
Fair
Analyst50.6% Upside
Market Cap4.85 B
P/E-9.4x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
Elicio Therapeutics Inc (ELTX)
Fair Value0.2% Upside
Fair
Analyst527.0% Upside
Market Cap74.108 M
P/E-1.9x
Yield0.0%
HealthWeak
NASDAQ
Elutia Inc (ELUT)
Fair Value15.3% Upside
Fair
Analyst473.4% Upside
Market Cap38.55 M
P/E-1.8x
Yield0.0%
HealthFair
NASDAQ
Equillium Inc (EQ)
Fair Value-5.1% Downside
Fair
Analyst292.5% Upside
Market Cap142.9 M
P/E-7.2x
Yield0.0%
HealthFair
NASDAQ
Erasca Inc (ERAS)
Fair Value-18.7% Downside
Overvalued
Analyst22.4% Upside
Market Cap6.38 B
P/E-23.3x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
High-Beta Momentum
Evaxion AS (EVAX)
Fair Value23.2% Upside
Undervalued
Analyst277.5% Upside
Market Cap24.604 M
P/E-2.5x
Yield0.0%
HealthGood
NASDAQ
Exagen Inc (XGN)
Fair Value-44.0% Downside
Overvalued
Analyst48.2% Upside
Market Cap155.8 M
P/E-8.5x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
Exicure Inc (XCUR)
Fair Value29.8% Upside
Undervalued
Market Cap9.816 M
P/E-1.0x
Yield0.0%
HealthWeak
NASDAQ
Foghorn Therapeutics Inc (FHTX)
Fair Value9.3% Upside
Fair
Analyst134.5% Upside
Market Cap285.3 M
P/E-3.8x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Gain Therapeutics Inc (GANX)
Fair Value10.2% Upside
Fair
Analyst300.0% Upside
Market Cap75.071 M
P/E-3.6x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Gossamer Bio Inc (GOSS)
Fair Value38.5% Upside
Undervalued
Market Cap88.726 M
P/E-0.5x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
Greenwich Lifesciences Inc (GLSI)
Fair Value-22.6% Downside
Overvalued
Analyst296.1% Upside
Market Cap210.6 M
P/E-9.5x
Yield0.0%
HealthWeak
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
GRI Bio Inc (GRI)
Fair Value19.6% Upside
Undervalued
Market Cap2.816 M
P/E-0.2x
Yield0.0%
HealthFair
NASDAQ
HCW Biologics Inc (HCWB)
Fair Value24.1% Upside
Undervalued
Analyst774.6% Upside
Market Cap4.297 M
P/E-0.2x
Yield0.0%
HealthFair
NASDAQ
Humacyte Inc (HUMA)
Fair Value2.7% Upside
Fair
Analyst181.2% Upside
Market Cap192 M
P/E-2.1x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
I Mab (NBP)
Fair Value59.0% Upside
Bargain
Analyst387.8% Upside
Market Cap190.8 M
P/E-2.1x
Yield0.0%
HealthFair
NASDAQ
Ideaya Biosciences Inc (IDYA)
Fair Value-6.5% Downside
Fair
Analyst47.1% Upside
Market Cap3.484 B
P/E-19.9x
Yield0.0%
HealthGood
NASDAQ
Immatics NV (IMTX)
Fair Value-17.5% Downside
Fair
Analyst82.9% Upside
Market Cap1.282 B
P/E-5.4x
Yield0.0%
HealthFair
NASDAQ
Featured in
Small-Cap Stocks
Immuneering Corp (IMRX)
Fair Value23.1% Upside
Undervalued
Analyst329.5% Upside
Market Cap284.7 M
P/E-5.2x
Yield0.0%
HealthFair
NASDAQ
Immunocore Holdings PLC (IMCR)
Fair Value10.9% Upside
Fair
Analyst91.0% Upside
Market Cap1.691 B
P/E-61.4x
Yield0.0%
HealthGood
NASDAQ
Featured in
Small-Cap Stocks
Immunome Inc (IMNM)
Fair Value-18.4% Downside
Overvalued
Analyst40.2% Upside
Market Cap2.838 B
P/E-12.9x
Yield0.0%
HealthFair
NASDAQ
Immunovant Inc (IMVT)
Fair Value-11.7% Downside
Fair
Analyst19.8% Upside
Market Cap8.124 B
P/E-16.0x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Momentum Stocks
In8bio Inc (INAB)
Fair Value36.1% Upside
Undervalued
Analyst532.0% Upside
Market Cap9.454 M
P/E-0.5x
Yield0.0%
HealthFair
NASDAQ
Inhibikase Therapeutics Inc (IKT)
Fair Value-22.7% Downside
Overvalued
Analyst149.0% Upside
Market Cap476.8 M
P/E-9.2x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
Small-Cap Stocks